OMVs increase the permeability of the blood-brain barrier and promote the activation of astrocytes and microglia, which in turn induces an inflammatory response and the hyperphosphorylation of tau protein via activation of the GSK-3β pathway, ultimately leading to cognitive impairment [104]. This evidence concerns the gene MAPT and Cognitive impairment.